TY - JOUR
T1 - A simplified gas chromatographic method for quantifying the sevoflurane metabolite hexafluoroisopropanol
AU - Morgan, S. E.
AU - Frink, E. J.
AU - Gandolfi, A. J.
PY - 1994
Y1 - 1994
N2 - Background: The results of sevoflurane biotransformation (fluoromethyl- 1,1,1,3,3,3,-hexafluoro-2-propyl ether) to inorganic fluoride have been examined. However, these investigations have lacked a simplified assay for determining the primary organic metabolite, hexafluoroisopropanol. Previous attempts have involved extensive extraction steps, complicated derivatization techniques, or sophisticated detectors. Methods: After enzymatic hydrolysis of conjugates, hexafluoroisopropanol is detected readily using a head space gas chromatographic analysis with a flame ionization detector. Results: The gas chromatographic technique was linear from 10 to 800 μM with a correlation coefficient of 0.999. The detection limit was 10 μM in urine and 25 μM in blood. Conclusions: This simplified approach does not require the extraction, derivatization, or mass spectrometric detectors of previous methods. As sevoflurane utilization and research increases, this assay should allow for a variety of laboratory and clinical disposition studies to be performed.
AB - Background: The results of sevoflurane biotransformation (fluoromethyl- 1,1,1,3,3,3,-hexafluoro-2-propyl ether) to inorganic fluoride have been examined. However, these investigations have lacked a simplified assay for determining the primary organic metabolite, hexafluoroisopropanol. Previous attempts have involved extensive extraction steps, complicated derivatization techniques, or sophisticated detectors. Methods: After enzymatic hydrolysis of conjugates, hexafluoroisopropanol is detected readily using a head space gas chromatographic analysis with a flame ionization detector. Results: The gas chromatographic technique was linear from 10 to 800 μM with a correlation coefficient of 0.999. The detection limit was 10 μM in urine and 25 μM in blood. Conclusions: This simplified approach does not require the extraction, derivatization, or mass spectrometric detectors of previous methods. As sevoflurane utilization and research increases, this assay should allow for a variety of laboratory and clinical disposition studies to be performed.
KW - Anesthetic gases: sevoflurane
KW - Biotransformation: metabolite
KW - Hexafluoroisopropanol
KW - Instrumentation: gas chromatography
UR - http://www.scopus.com/inward/record.url?scp=0028157263&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028157263&partnerID=8YFLogxK
U2 - 10.1097/00000542-199401000-00027
DO - 10.1097/00000542-199401000-00027
M3 - Article
C2 - 8291710
AN - SCOPUS:0028157263
SN - 0003-3022
VL - 80
SP - 201
EP - 205
JO - Anesthesiology
JF - Anesthesiology
IS - 1
ER -